Clariwill Pharmaceuticals Private Limited
About Clariwill Pharmaceuticals Private Limited
Data last updated:
Clariwill Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 14 November 2022.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2022PTC063389.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dushyant Chandrawal and Yogesh Singh Chauhan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 292 Vyanktesh Nagar, Indore, Madhya Pradesh, India – 452005.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.26 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3,444 (net margin 0.4%) and EBITDA of ₹3,444 (EBITDA margin 0.4%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address292 Vyanktesh Nagar, Indore, Madhya Pradesh, India – 452005
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Clariwill Pharmaceuticals Private Limited
The main business activity of Clariwill Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Clariwill Pharmaceuticals Private Limited FY 2025 filings available
Clariwill Pharmaceuticals Private Limited reported revenue of ₹9.26 Lakh (up 92480% YoY) for FY 2024.
Financial Statement Summary of Clariwill Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹3,444 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹3,444 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Clariwill Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.4% | •••• |
| Net Profit Margin | 0.4% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Clariwill Pharmaceuticals are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Clariwill Pharmaceuticals Private Limited
Clariwill Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ptrevas Pharmaceuticals Private Limited | ₹9.31 Lakh (FY 2019) | •••• | •••• | -28.0% | •••• | Sangareddy, Telangana, India |
| Macdus Pharmaceuticals Private Limited | ₹9.31 Lakh (FY 2023) | •••• | •••• | 365.0% | •••• | Pathanamthitta, Kerala, India |
| Kalki Pharmaceuticals Private Limited | ₹9.31 Lakh (FY 2023) | •••• | •••• | •••• | Raipur, Chhattisgarh, India | |
| Bcure&Care Pharmaceuticals Private Limited | ₹9.28 Lakh (FY 2023) | •••• | •••• | 72.0% | •••• | Delhi, India |
| Samnvay Pharmaceuticals Private Limited | ₹9.27 Lakh (FY 2023) | •••• | •••• | 60.0% | •••• | Jaipur, Rajasthan, India |
| Clariwill Pharmaceuticals Private Limited this company | ₹9.26 Lakh (FY 2024) | •••• | •••• | 92480.0% | •••• | Indore, Madhya Pradesh, India |
| Bioreo Chemicals & Pharmaceuticals (OPC) Private Limited | ₹9.25 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Everest Pharmaceuticals Pvt Ltd | ₹9.24 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Kolkata, West Bengal, India |
| Jorkar Pharmaceuticals Private Limited | ₹9.24 Lakh (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Glez Pharmaceuticals Private Limited | ₹9.23 Lakh (FY 2022) | •••• | •••• | 18.0% | •••• | Gwalior, Madhya Pradesh, India |
| Mother India Pharmaceuticals Private Limited | ₹9.21 Lakh (FY 2024) | •••• | •••• | -7.0% | •••• | Secunderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Clariwill Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Clariwill Pharmaceuticals Private Limited
Clariwill Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dushyant Chandrawal | Director | 14 Nov 2022 | 3 Years 10 Months | Current |
| Yogesh Singh Chauhan | Director | 14 Nov 2022 | 3 Years 10 Months | Current |
Charges & Borrowings of Clariwill Pharmaceuticals Private Limited
Clariwill Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Clariwill Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Clariwill Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Clariwill Pharmaceuticals Private Limited
Clariwill Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Dushyant Chandrawal was appointed as Director on 14 Nov 2022.
Credit Ratings, Litigation & Regulatory Alerts for Clariwill Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Clariwill Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Clariwill Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Clariwill Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Clariwill Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clariwill Pharmaceuticals Private Limited
Clariwill Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 14 November 2022 (4+ years old) and is registered under CIN U24230MP2022PTC063389.
Clariwill Pharmaceuticals reported revenue of ₹9.26 Lakh for FY 2024 (up 92480% YoY).
Clariwill Pharmaceuticals has 2 current directors:
- Dushyant Chandrawal - Director
- Yogesh Singh Chauhan - Director
Clariwill Pharmaceuticals reported a net profit of ₹3,444 (net margin 0.4%) and EBITDA of ₹3,444 (EBITDA margin 0.4%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Clariwill Pharmaceuticals is U24230MP2022PTC063389. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clariwill Pharmaceuticals was incorporated on 14 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Clariwill Pharmaceuticals by revenue are Ptrevas Pharmaceuticals Private Limited, Macdus Pharmaceuticals Private Limited, Kalki Pharmaceuticals Private Limited, Bcure&Care Pharmaceuticals Private Limited, Samnvay Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Dushyant Chandrawal was appointed as Director on 14 Nov 2022. Yogesh Singh Chauhan was appointed as Director on 14 Nov 2022.
The registered office of Clariwill Pharmaceuticals is at 292 Vyanktesh Nagar, Indore, Madhya Pradesh, India – 452005.
Clariwill Pharmaceuticals has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh.
Clariwill Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.